Skip to main content

NSF To Host Pharma Compliance to Performance Conference

NSF will host its 2nd pharmaceutical conference in London on November 14th, 2024.

NSF’s Compliance to Performance conference will look at two of the most pressing issues in global pharma: artificial intelligence and supply chain disruptions.

We are bringing together an exciting panel of speakers from industry, trade associations, regulatory bodies, and academia. Speakers include Martin Lush, a renowned industry veteran and globally regarded expert about AI advancements in pharma manufacturing, and Paul Fleming, Technical Director of the British Generic Manufacturers Association and British Biosimilars Association. Paul will be talking about supply chain shortages impacting the industry.

The conference will be hosted by Lynne Ensor, Senior Global Managing Director of NSF’s Pharma Biotech division. Lynne has enjoyed a long career with extensive experience, including fourteen years in senior roles with the USFDA.

The event takes place during World Quality Week and adopts the theme of Compliance to Performance.

Book your place today

Join us on November 14th at The Royal Society of Chemistry for this insightful conference and the opportunity to meet with speakers and industry peers.
Tickets are available here

How NSF Can Help You

Get in touch to find out how we can help you and your business thrive.

What’s New with NSF

  • Spritzer Becomes First Malaysian Bottled Water Brand Certified by NSF for Beverage Quality

    May 21, 2026
    The leading Malaysian bottled water and beverages brand has earned NSF certification from ANSI-Accredited Product Certification Body – Accreditation #0216.
    Read the Story
  • NSF Annual Review and Impact Report 2025 Now Live

    April 20, 2026
    NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.
    Read the Story
  • Visit NSF at Making Pharma 2026

    April 10, 2026
    Connect with our experts to discover how we help leading pharmaceutical and biotechnology companies achieve regulatory compliance and operational excellence.
    Read the Story